NYSE - Nasdaq Real Time Price
USD
Teva Pharmaceutical Industries Limited (TEVA)
41.23
+1.26
(+3.15%)
As of 12:33:27 PM EDT. Market Open.
Trade TEVA on Coinbase
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutTeva is approaching its third-quarter results with analysts expecting lower revenue and earnings, despite stronger branded-drug growth in selected products. Recent developments include FDA approval for WELTRUZA, an acquisition expanding its neuroscience pipeline, and encouraging mid-stage data for duvakitug in inflammatory bowel disease.[1][2][3][4]
